PL1608982T3 - Diagnozowanie autyzmu - Google Patents

Diagnozowanie autyzmu

Info

Publication number
PL1608982T3
PL1608982T3 PL04716392T PL04716392T PL1608982T3 PL 1608982 T3 PL1608982 T3 PL 1608982T3 PL 04716392 T PL04716392 T PL 04716392T PL 04716392 T PL04716392 T PL 04716392T PL 1608982 T3 PL1608982 T3 PL 1608982T3
Authority
PL
Poland
Prior art keywords
seq
autism
diagnosis
peptides
skithrihwesasll
Prior art date
Application number
PL04716392T
Other languages
English (en)
Inventor
Anders Grubb
Original Assignee
Momeni Naghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momeni Naghi filed Critical Momeni Naghi
Publication of PL1608982T3 publication Critical patent/PL1608982T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
PL04716392T 2003-03-04 2004-03-02 Diagnozowanie autyzmu PL1608982T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism
EP04716392A EP1608982B9 (en) 2003-03-04 2004-03-02 Diagnosis of autism
PCT/SE2004/000193 WO2004079371A1 (en) 2003-03-04 2004-03-02 Diagnosis of autism

Publications (1)

Publication Number Publication Date
PL1608982T3 true PL1608982T3 (pl) 2008-01-31

Family

ID=20290572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04716392T PL1608982T3 (pl) 2003-03-04 2004-03-02 Diagnozowanie autyzmu

Country Status (19)

Country Link
US (1) US8268576B2 (pl)
EP (1) EP1608982B9 (pl)
JP (1) JP4452715B2 (pl)
KR (1) KR101096487B1 (pl)
CN (1) CN1795386B (pl)
AT (1) ATE371192T1 (pl)
AU (1) AU2004217571B2 (pl)
BR (1) BRPI0408067A (pl)
CA (1) CA2518066C (pl)
DE (1) DE602004008439T2 (pl)
DK (1) DK1608982T3 (pl)
ES (1) ES2293234T3 (pl)
NZ (1) NZ542149A (pl)
PL (1) PL1608982T3 (pl)
PT (1) PT1608982E (pl)
RU (1) RU2340900C2 (pl)
SE (1) SE0300586L (pl)
WO (1) WO2004079371A1 (pl)
ZA (1) ZA200507082B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677556B2 (ja) * 2005-04-22 2011-04-27 国立大学法人 千葉大学 自閉症の診断薬
SG182971A1 (en) * 2007-07-26 2012-08-30 Phenomenome Discoveries Inc Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
WO2012082056A1 (en) 2010-12-16 2012-06-21 Autism Biodiagnosis Ltd. Novel biomarker and uses thereof in diagnosis, treatment of autism
WO2014018468A1 (en) 2012-07-22 2014-01-30 Indiana University Research And Technology Corporation Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd
US10634677B2 (en) 2013-10-14 2020-04-28 Indiana University Research And Technology Corporation Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASD
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
KR102083245B1 (ko) 2017-03-10 2020-03-02 스핑고브레인 주식회사 정신장애의 진단 방법
US11131681B2 (en) * 2017-03-10 2021-09-28 Dr. Raymond Laboratories, Inc. Method for diagnosing psychiatric disorders
RU2643760C1 (ru) * 2017-08-07 2018-02-05 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Способ определения необходимости использования психофармакотерапии у пациентов с расстройствами аутистического спектра на момент их обследования
KR20190106442A (ko) 2018-03-09 2019-09-18 스핑고브레인 주식회사 태지, 양수 또는 제대혈을 이용한 정신장애의 진단 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273683A1 (en) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Diagnostic markers for human disorders
IT1303675B1 (it) * 1998-08-04 2001-02-23 Radim S P A Metodo di determinazione di peptidi utilizzati come marker per ladiagnosi dell'autismo
JP2003512856A (ja) 1999-11-04 2003-04-08 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ウテログロビン様ポリヌクレオチド、ポリペプチド、および抗体
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

Also Published As

Publication number Publication date
NZ542149A (en) 2008-03-28
WO2004079371A1 (en) 2004-09-16
CA2518066A1 (en) 2004-09-16
KR101096487B1 (ko) 2011-12-20
CN1795386A (zh) 2006-06-28
AU2004217571B2 (en) 2009-03-12
RU2005130641A (ru) 2006-02-10
US20120149038A1 (en) 2012-06-14
RU2340900C2 (ru) 2008-12-10
ZA200507082B (en) 2007-02-28
AU2004217571A1 (en) 2004-09-16
KR20060006774A (ko) 2006-01-19
JP4452715B2 (ja) 2010-04-21
EP1608982A1 (en) 2005-12-28
JP2006519391A (ja) 2006-08-24
SE0300586L (sv) 2004-09-05
ES2293234T3 (es) 2008-03-16
EP1608982B9 (en) 2008-07-23
CA2518066C (en) 2011-05-10
PT1608982E (pt) 2007-11-09
DK1608982T3 (da) 2007-11-26
SE0300586D0 (sv) 2003-03-04
EP1608982B1 (en) 2007-08-22
DE602004008439D1 (de) 2007-10-04
ATE371192T1 (de) 2007-09-15
DE602004008439T2 (de) 2008-05-21
CN1795386B (zh) 2010-08-25
US8268576B2 (en) 2012-09-18
BRPI0408067A (pt) 2006-02-14

Similar Documents

Publication Publication Date Title
HK1107030A1 (en) Oligopeptides for reducing elevated blood urea concentration
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
IL129299A0 (en) Monoclonal antibodies antigens and diagnosis of malignant diseases
PL1608982T3 (pl) Diagnozowanie autyzmu
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
WO2005042770A3 (en) Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
WO2002014537A3 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
WO2004043223A3 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2002057795A3 (en) Methods of diagnosis and treatment of osteoporosis
WO2004029285A3 (en) Methods for detecting endocrine cancer
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
TR200200667T2 (tr) Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları.
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
EP1780215A4 (en) MORBUS CROHN ANTIBODY PEPPTH PEPTIDE AND REAGENT TO TEST MORBUS CROHN
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
DE602005012575D1 (en) Isostere transformation
EP2290093A3 (fr) Procédé de détection de la PRP utilisant une molécule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0223655D0 (en) Method of diagnosis
WO2002008424A1 (fr) Genes abca2 humain et de rat
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
TW200502398A (en) Use of peptidylarginine deiminase type IV
PT1527197E (pt) Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização
WO2002074793A3 (en) Novel peptides for the diagnosis of schizophrenia
ATE420210T1 (de) Diagnose des brustkrebsrisikos